Searchable abstracts of presentations at key conferences in endocrinology

ea0065p147 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Lobectomy for thyroid cancer and thyroglobulin as a tumor marker for long term follow up: current controversies and clarification

Jeeyavudeen Mohammad Sadiq , Graveling Alex , Shakeel Muhammad , Smart Louise , Tasleem Sadia , Aspinall Sebastian , Abraham Prakash

Background: The accuracy of thyroglobulin (Tg) as a tumour marker following lobectomy for differentiated thyroid cancer (DTC) remains controversial. A Tg (<10 µg/l) looked promising in identifying those without clinically apparent recurrence after median 51 months of follow-up. Longer term follow up allows assessment of the diagnostic utility of thyroglobulin in predicting relapse.Methods: Ninety-nine patients who underwent lobectomy for DTC wer...